The Telix Pharmaceuticals Ltd (ASX: TLX) share price is rated as a buy by numerous brokers. Here’s what’s so appealing.

A collaboration between researchers in Santa Cruz and Puebla, Mexico, is working to eliminate the bacterial genes driving ...

Cancer remains a leading cause of global morbidity and mortality. Traditional therapies like chemotherapy and radiotherapy ...

The global bioconjugation market is set to witness a growth rate of ~13% in the next 5 years. Increasing demand for targeted ...

Discover the top biotech deals of September 2025, as four billion-dollar acquisitions took place and several licensing deals ...

Carbon monoxide is also known as the “silent killer” because it has no odor, taste, or color. In the United States alone, it ...

The Jingjing Wu group at the National Key Laboratory of Synergistic Materials Creation/Frontier Science Center for Transformative Molecules (FSCTM) at ...

Lead suprachoroidal capsid coAAV-SCS-01 demonstrated up to 26x outperformance of other capsids in targeting RPE-choroid and ...

Dyne Therapeutics' FORCE platform targets rare diseases with promise, but high valuation and trial risks limit upside. Find ...

Pushing the limits of size constraints in chemistry, an 8-nanometer 18-porphyrin nanoring (c-P18) becomes the largest known cyclic molecule to exhibit detectable global aromaticity. This phenomenon, ...

Cancer remains a leading cause of global morbidity and mortality. Traditional therapies like chemotherapy and radiotherapy are often limited by their ...